Position in SIGA
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$262
-$417 QoQ
Shares Held
72
-43.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 160 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $550,595 across 35 Drug Manufacturers - Specialty & Generic names. SIGA ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
6,073 | $257,920 | |
| 2 | ZTS |
Zoetis Inc.
|
770 | $55,331 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
255 | $42,977 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,285 | $36,627 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
54 | $29,258 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,180 | $29,039 | |
| 7 | VTRS |
Viatris Inc
|
895 | $14,212 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
348 | $12,064 |
All Filings in SIGA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $262 | 72 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $679 | 127 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $403 | 66 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,163 | 455 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||